InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2429

Thursday, 01/10/2019 4:06:46 PM

Thursday, January 10, 2019 4:06:46 PM

Post# of 3283
I don't think they need to wait for the 87 patients to mature. FDA might agree to 40 or 50 patients. In that case, SPPI could probably re-submit in the 1st quarter. Wouldn't it be a nice surprise to get BTD in the second quarter?

It is possible.

BTW: I've been arguing that cORR is likely to be 60% +/- 10% based on close analysis of the MDACC data and the Zenith20 trial improvements.